Expression of TGF-β receptor ALK-5 has a negative impact on outcome of patients with acute myeloid leukemia

Standard

Expression of TGF-β receptor ALK-5 has a negative impact on outcome of patients with acute myeloid leukemia. / Otten, J; Schmitz, L; Vettorazzi, E; Schultze, A; Marx, A H; Simon, R; Krauter, J; Loges, S; Sauter, G; Bokemeyer, C; Fiedler, W.

in: LEUKEMIA, Jahrgang 25, Nr. 2, 01.02.2011, S. 375-9.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{1fc11e29a7b24752915ebd70b88fda35,
title = "Expression of TGF-β receptor ALK-5 has a negative impact on outcome of patients with acute myeloid leukemia",
keywords = "Activin Receptors, Type II, Adult, Female, Humans, Leukemia, Myeloid, Acute, Male, Middle Aged, Prognosis, Protein-Serine-Threonine Kinases, Receptors, Transforming Growth Factor beta, Treatment Outcome, Young Adult",
author = "J Otten and L Schmitz and E Vettorazzi and A Schultze and Marx, {A H} and R Simon and J Krauter and S Loges and G Sauter and C Bokemeyer and W Fiedler",
year = "2011",
month = feb,
day = "1",
doi = "10.1038/leu.2010.273",
language = "English",
volume = "25",
pages = "375--9",
journal = "LEUKEMIA",
issn = "0887-6924",
publisher = "NATURE PUBLISHING GROUP",
number = "2",

}

RIS

TY - JOUR

T1 - Expression of TGF-β receptor ALK-5 has a negative impact on outcome of patients with acute myeloid leukemia

AU - Otten, J

AU - Schmitz, L

AU - Vettorazzi, E

AU - Schultze, A

AU - Marx, A H

AU - Simon, R

AU - Krauter, J

AU - Loges, S

AU - Sauter, G

AU - Bokemeyer, C

AU - Fiedler, W

PY - 2011/2/1

Y1 - 2011/2/1

KW - Activin Receptors, Type II

KW - Adult

KW - Female

KW - Humans

KW - Leukemia, Myeloid, Acute

KW - Male

KW - Middle Aged

KW - Prognosis

KW - Protein-Serine-Threonine Kinases

KW - Receptors, Transforming Growth Factor beta

KW - Treatment Outcome

KW - Young Adult

U2 - 10.1038/leu.2010.273

DO - 10.1038/leu.2010.273

M3 - SCORING: Journal article

C2 - 21304536

VL - 25

SP - 375

EP - 379

JO - LEUKEMIA

JF - LEUKEMIA

SN - 0887-6924

IS - 2

ER -